Propanc Biopharma plans Phase 1b trial for cancer drug PRP
Go back to Propanc Biopharma plans Phase 1b trial for cancer drug PRP| (NASDAQ: PPCB) | Delayed: 0.61 -0.02 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.63 | 52 Week High | $ | |||
| Open | $0.66 | 52 Week Low | $ | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $ | |||
| Volume | 160,446 | |||||
| (NASDAQ: RVMD) | Delayed: 190.95 -5.99 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $196.94 | 52 Week High | $ | |||
| Open | $197.00 | 52 Week Low | $ | |||
| Day High | $197.10 | P/E | N/A | |||
| Day Low | $188.18 | EPS | $ | |||
| Volume | 5,939,946 | |||||
